Skip to main content

stock

BIAF · bioAffinity Technologies, Inc.

What bioAffinity Technologies, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live BIAF price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BIAF.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
8,101,725 as of 2026-08-03 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-209.8%
Net
-257.3%

Returns

ROE
-402.9%
ROA
-199.3%

Health

Current ratio
1.4x
Debt/equity
—

Deep value

NCAV
$14,798
NCAV per share
$0.00
Price/NCAV
Locked
NNWC
-$1.38M
NNWC per share
-$0.17
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$1.51M—-$3.33M-$3.37M
10-Q filed 2026-08-07
2026-03-31$1.35M—-$3.62M-$3.63M
10-Q filed 2026-05-11
2025-12-31$1.59M—-$3.14M-$3.14M
10-K filed 2026-03-16
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$1.45M—-$2.29M-$5.05M
10-Q filed 2025-11-14
2025-06-30$1.27M—-$2.52M-$4.06M
10-Q filed 2026-08-07
2025-03-31$1.85M—-$2.63M-$2.66M
10-Q filed 2026-05-11
2024-12-31$2.21M—-$2.95M-$2.97M
10-K filed 2026-03-16
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$2.35M—-$1.97M-$2.00M
10-Q filed 2025-11-14
Assets
$7.62M
Equity
$3.77M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$6.16M-$10.57M-$14.91M-$9.39M
2024-12-31$9.36M-$8.95M-$9.04M-$7.34M
2023-12-31$2.53M-$7.97M-$7.94M-$6.06M
2022-12-31$4,803-$4.01M-$8.15M-$4.29M
2021-12-31—-$2.21M-$6.33M—

Company filings

since Thu Sep 3 · 4 offering filings in 12 months · since Thu Oct 9

events

  • Other event

    Other event
    Oct 68-K
  • Other event

    Other event
    Sep 308-K
  • Other event

    Other event
    Sep 228-K
  • Other event

    Other event
    Sep 178-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Sep 118-K
  • Other event

    Other event
    Sep 98-K

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

Funds

News

Stories that named BIAF, and the market events around them.

Sign in to see this

Board

The BIAF board could not be loaded.

Retry the BIAF board

nakagai

Signals on BIAF come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BIAF board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

bioAffinity Technologies, Inc. (BIAF): SEC filings, financials and insider trades · Nakagai